DE3104886A1 - Antibiotika actinomadura-l-31 a, b - Google Patents

Antibiotika actinomadura-l-31 a, b

Info

Publication number
DE3104886A1
DE3104886A1 DE19813104886 DE3104886A DE3104886A1 DE 3104886 A1 DE3104886 A1 DE 3104886A1 DE 19813104886 DE19813104886 DE 19813104886 DE 3104886 A DE3104886 A DE 3104886A DE 3104886 A1 DE3104886 A1 DE 3104886A1
Authority
DE
Germany
Prior art keywords
actinomadura
antibiotics
melting point
spectrum
antibiotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19813104886
Other languages
German (de)
English (en)
Other versions
DE3104886C2 (US06196068-20010306-M00005.png
Inventor
Yukio Miyazaki
Akio Tokyo Seino
Hideo Sugawara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kaken Pharmaceutical Co Ltd
Original Assignee
Kaken Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaken Chemical Co Ltd filed Critical Kaken Chemical Co Ltd
Publication of DE3104886A1 publication Critical patent/DE3104886A1/de
Application granted granted Critical
Publication of DE3104886C2 publication Critical patent/DE3104886C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/03—Actinomadura

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Unknown Constitution (AREA)
DE19813104886 1980-02-15 1981-02-11 Antibiotika actinomadura-l-31 a, b Granted DE3104886A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1664780A JPS56113791A (en) 1980-02-15 1980-02-15 Novel antibiotic and its preparation

Publications (2)

Publication Number Publication Date
DE3104886A1 true DE3104886A1 (de) 1982-04-15
DE3104886C2 DE3104886C2 (US06196068-20010306-M00005.png) 1988-06-23

Family

ID=11922133

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19813104886 Granted DE3104886A1 (de) 1980-02-15 1981-02-11 Antibiotika actinomadura-l-31 a, b

Country Status (5)

Country Link
US (1) US4328211A (US06196068-20010306-M00005.png)
JP (1) JPS56113791A (US06196068-20010306-M00005.png)
DE (1) DE3104886A1 (US06196068-20010306-M00005.png)
FR (1) FR2476127A1 (US06196068-20010306-M00005.png)
GB (1) GB2069500B (US06196068-20010306-M00005.png)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4578271A (en) * 1982-05-24 1986-03-25 Fujisawa Pharmaceutical Co., Ltd. Biologically active WS 6049 substances, a process for the production thereof and their pharmaceutical compositions
GR78648B (US06196068-20010306-M00005.png) * 1982-07-26 1984-09-27 Bristol Myers Co
NZ208013A (en) * 1983-05-16 1987-07-31 Bristol Myers Co Antitumour antibiotic bbm-1675 and production by cultivating actinomadura verrucosospora
US5001112A (en) * 1988-04-12 1991-03-19 Bristol-Myers Company Antitumor antibiotic kedarcidin
US5534420A (en) * 1988-07-28 1996-07-09 Eli Lilly And Company Biotransformation of glycopeptide antibiotics
US5256548A (en) * 1990-11-21 1993-10-26 Bristol-Myers Squibb Company Antiviral antibiotic BU-4344V
US5140101A (en) * 1990-11-21 1992-08-18 Bristol-Myers Squibb Company Antiviral antibiotic BU-4344V
US6586393B2 (en) * 2000-12-04 2003-07-01 Biosearch Italia S.P.A. Antibiotics GE 23077, pharmaceutically acceptable salts and compositions, and use thereof
JP2002282150A (ja) * 2001-03-22 2002-10-02 Silver Kogyo Kk 浴 槽

Non-Patent Citations (17)

* Cited by examiner, † Cited by third party
Title
Actinomycetes and Related Microorganismus 12, 1, S.30, 1977 *
Antibiotics Annual, S.554, 1955/56 *
Antibiotiki 17, 11, S.965, 1972 *
Antibiotiki 20, 5, S.404, 1975 *
Hakko Kobaku 49, 11, S.904, 1971 *
Int. J. Syst. Boderiol, Bd. 16, S.313-340, 1966 *
Int. J. Systematic Bacteriology 19, S.391-512, 1969 *
J. Antibiot. 21, 320 k, 1968 *
J. Antibiot. 21, 429, 1968 *
J. Antibiot. 21, 44, 1968 *
J. Antibiot. 22, 364, 1969 *
J. Antibiot. 23, 113, 1970 *
J. Antibiot. 29, 501, 1976 *
J. Antibiot. A 12, 1, 1959 *
J. Antibiot. A 18, 68, 1965 *
J. Antibiot. A 20, 194, 1967 *
Microbiologa 44, S.524, 1975 *

Also Published As

Publication number Publication date
GB2069500A (en) 1981-08-26
DE3104886C2 (US06196068-20010306-M00005.png) 1988-06-23
US4328211A (en) 1982-05-04
FR2476127B1 (US06196068-20010306-M00005.png) 1983-12-30
FR2476127A1 (fr) 1981-08-21
JPS6254320B2 (US06196068-20010306-M00005.png) 1987-11-13
JPS56113791A (en) 1981-09-07
GB2069500B (en) 1983-06-02

Similar Documents

Publication Publication Date Title
DE3783588T2 (de) Neue verbindungen dc-88a und dc-89a1 und deren herstellungsverfahren.
DE2754326C2 (de) Antibiotikum AM 2282, seine Herstellung und Arzneimittel
EP0003616A2 (de) Neue Aminozucker-Derivate, ihre Herstellung und Amylase-hemmende Mittel
DE3013246C2 (US06196068-20010306-M00005.png)
DE3104886C2 (US06196068-20010306-M00005.png)
DE2730952C2 (de) Antibiotikum Sporamycin, Verfahren zu seiner Herstellung und diese Verbindung enthaltendes Arzneimittel
DE3048421C2 (de) Antibiotische Substanz, Verfahren zu deren Herstellung und antimykotisches Mittel, welches diese enthält
DE3136675A1 (de) Neues peptid und dessen herstellung
DE69816621T2 (de) Macrolide mit antitumoraktivität
DE2833689C2 (US06196068-20010306-M00005.png)
DE2918711A1 (de) Macrolid-antibiotika, verfahren zu ihrer gewinnung und diese antibiotika enthaltende pharmazeutische praeparate
DE3885361T2 (de) Verbindung DC-107 und Verfahren zu deren Herstellung.
DE2950980C2 (de) Antibiotikum BN-183B und Arzneimittel, welche dieses enthalten
DE3003359C2 (US06196068-20010306-M00005.png)
DE2708493A1 (de) Neues antibiotikum am-1042
DE69102467T2 (de) Physiologisch aktive Verbindungen, Benastatine A und B, ihre Herstellung und Anwendung.
DE2532589A1 (de) Polypeptid und verfahren zur herstellung desselben und mittel mit einem gehalt desselben
DE69129924T2 (de) Antibiotikum und Verfahren zu seiner Herstellung
DE3407979C2 (US06196068-20010306-M00005.png)
DE3881812T2 (de) Physiologisch aktive Substanzen, Probestin und Prostatin und deren Herstellung.
DE2806220A1 (de) Biologisch reine kultur des neuen mikroorganismus streptomyces espinosus subsp. acanthus, unter seiner verwendung hergestelltes antibiotikum acanthomycin und verfahren zur herstellung des acanthomycins
DE2818544A1 (de) Antibiotikum sf-1942, verfahren zu dessen herstellung und pharmazeutische zusammensetzung, die das antibiotikum sf-1942 enthaelt
DE1961764C3 (de) Verfahren zur Gewinnung von antibiotisch wirksamem Aabomycin-A mit der Summenformel C tief 39-40 H tief 65-67 O tief 11 N
DD210075A5 (de) Verfahren zur herstellung des antitumorantibiotikums bbm-1644
DE2830856A1 (de) Neue antibiotisch wirksame verbindungen, verfahren zu deren herstellung und arzneimittel

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee